-transparent.png){kind=logo}
The most frequent complications in patients with the terminal stage of chronic renal insufficiency are infections of various severity. The problem of the antibacterial therapy choice is especially urgent because of a high frequency of antibiotic resistant strains and the necessity to correct the treatment regimens in regard to the severity of the renal failure. The pharmacokinetics of lomefloxacin, a new fluoroquinolone, was studied in the treatment of patients with the terminal stage of chronic renal insufficiency treated by programmed hemodialysis. Lomefloxacin was administered orally in a dose of 400 mg at an interval of 48 hours 24 hours prior to the hemodialysis application. There was observed a decrease in the maximum serum concentration of the drug by comparison to that in healthy persons which could be due to slow absorption of the drug and hyperhydration in the patients because of anuria. In the treatment of such patients it is necessary to provide high serum concentrations of lomefloxacin attainable by using higher single doses of the drug.
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
January 1979,
Therapie,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
December 2001,
Klinichna khirurhiia,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
January 1977,
Terapevticheskii arkhiv,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
August 1968,
L' Infirmiere,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
January 1992,
Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
October 2001,
Cornea,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
January 1985,
Chemotherapy,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
December 1994,
The American journal of cardiology,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
January 1979,
Bollettino dell'Istituto sieroterapico milanese,
S E Kolendo, and
P A Vorob'ev, and
L I Dvoretskiĭ, and
G N Izotova, and
A V Miagkov, and
G S Shvyreva, and
S V Iakovlev
May 1971,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
